Official Title: A Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study to Evaluate the Immunogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older

Actual Study Start Date : June 6, 2022

Estimated Primary Completion Date : August 22, 2023

Estimated Study Completion Date : August 22, 2023